Mary Agnes Carey has covered health reform and federal health policy for more than 15 years as an editor at CQ HealthBeat
, as Capitol Hill Bureau Chief for Congressional Quarterly
and at Dow Jones Newswires. A frequent radio and television commentator, recently featured on the Nightly Business Report, the PBS NewsHour and on NPR affiliates nationwide, Mary Agnes has a thorough understanding of both the policy and politics of health reform. She worked for newspapers in Connecticut and Pennsylvania, and has a master's degree in journalism from Columbia University. | Contact: MaryAgnesC@kff.org
Congressional staffers are among those most likely to experience changes in their coverage options as a result of the Affordable Care Act.
The proposal would keep physician pay at current levels but offer them incentives for quality improvements.
The health law gives consumers until March 31 to sign up for health insurance, but it may be weeks before coverage begins. So the administration says it will not penalize anyone who signs up by that date.
Lawmakers have until Dec. 13 to reach agreement under legislation ending the shutdown of the government and raising the debt ceiling.
This little-known provision of the health law has been --at times -- in the Senate negotiations on the budget.
Getting rid of the tax, which helps raise money to fund the health law, might help break the budget battle logjam.
The online exchanges that open Oct. 1 are not aimed at Medicare beneficiaries, but the 2010 health law does affect seniors in other ways.
These marketplaces open Oct. 1 and will allow individuals and small businesses to compare insurance coverage.
In a letter that the administration described as a "blatant and shameful attempt to intimidate," the Republican House members direct groups to provide a written description of the work they intend to do, the number of employees and volunteers, their duties and how much they’ll be paid.
John Castellani, the head of the Pharmaceutical Research and Manufacturers of America, notes support for health overhaul but says efforts to change Medicare Part D program and companies’ control of biologic drugs "would do serious harm to our industry."